Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia

Gynecologic Oncology

Volumn 29, Issue 1, 1988, Pages 82-86

  Rotmensch, Jacob ^a   Rosenshein, Neil B ^b   Block, Barry S ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; PEPTIDE FRAGMENT;

ARTICLE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HYDATIDIFORM MOLE; PREGNANCY; TROPHOBLASTIC TUMOR; UTERUS CANCER;

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; COMPARATIVE STUDY; FEMALE; HUMAN; HYDATIDIFORM MOLE; PEPTIDE FRAGMENTS; PREGNANCY; TROPHOBLASTIC NEOPLASMS; UTERINE NEOPLASMS;

EID: 0023742415     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/0090-8258(88)90150-3     Document Type: Article

References (9)

1. Treatment of gestational trophoblastic disease
2. Hydatidiform mole: Diagnosis, management and long-term follow-up of 347 patients
3. Prognostic characteristics of serum human chorionic gonadotropin in titer regression following molar pregnancy
4. Chorionic gonadotropin determinations of hydatidiform mole and choriocarcinoma
5. Epidemiologic features of hydatidiform mole in The Netherlands.
6. Treatment of nonmetastatic gestational trophoblastic disease: Results of methotrexate alone versus methotrexate-folinic acid
7. Methotrexate with citrovorum factor rescue